Figure 2.
Left ventricular ejection fraction (LVEF) development before and after chemotherapy. Red data points indicate anthracycline‐induced cardiomyopathy (aCMP) patients with LVEF drop of >10% during chemotherapy. Averages for aCMP and non‐aCMP patients are displayed above.